Zobrazeno 1 - 10
of 226
pro vyhledávání: '"Aleksandrova En"'
Publikováno v:
Терапевтический архив, Vol 93, Iss 2, Pp 228-235 (2021)
Inflammatory bowel disease IBD (Crohns disease CD, ulcerative colitis UC) immune-mediated diseases of the digestive tract of unknown etiology. The basis of the pathogenesis of IBD is a violation of the protective mechanisms of the intestinal barrier
Publikováno v:
Annals of the Rheumatic Diseases. 80:1442.2-1443
Background:YKL-40 (chitinase-3-like 1 protein, human cartilage glycoprotein 39) is one of the major proteins secreted locally in the arthritic joint by activated macrophages, chondrocytes, synoviocytes and neutrophils, YKL-40 an important marker for
Autor:
M N Starovoytova, D. A. Varlamov, I A Guseva, M Yu Krylov, L. P. Ananyeva, Novikov Aa, Aleksandrova En, О А Koneva, Konovalova Nv, O. B. Ovsyannikova, O. V. Desinova
Publikováno v:
Терапевтический архив, Vol 89, Iss 5, Pp 20-25 (2017)
To examine the association of signal transducer and activator transcription 4 (STAT4) rs7574865 G/T polymorphism with a predisposition to systemic sclerosis (SSC) and associated clinical and autoimmune phenotypes in a Russian population.A total of 10
Publikováno v:
Poster Presentations.
Background CD4+ CD25+ Foxp3+ regulatory T (Treg) cells play a key role in maintaining peripheral tolerance and preventing autoimmune disease. Quantitative and/or qualitative deficiencies of Treg have been associated with immune disturbances in system
Autor:
N S Shornikova, S G Radenska-Lopovok, E B Rodionova, T N Safonova, E V Socol, S G Palshina, Natalya A Probatova, Aleksandrova En, Alla M. Kovrigina, V I Vasilyev, V R Gorodetsky, A I Pavlovskaya, N V Kokosadze, I V Gaiduk
Publikováno v:
Терапевтический архив, Vol 90, Iss 5, Pp 61-71 (2018)
Purpose of the study. To provide demographic, clinical, laboratory, ultrasound, radiological, morphological/ immunomorphological phenotype of IgG4-related ophthalmic diseases, which allowsmaking a differential diagnosis with granulomatous, autoimmune
Autor:
Aleksandrova En, Galina Lukina, Elena V. Tchetina, A.P. Aleksankin, Galina A. Markova, Aleksandr N. Kuzin, Anastasya N. Pivanova, S. Makarov
Publikováno v:
Arthritis
Arthritis, Vol 2016 (2016)
Arthritis, Vol 2016 (2016)
Objective. To clarify molecular mechanisms for the response to rituximab in a longitudinal study. Methods. Peripheral blood from 16 RA patients treated with rituximab for a single treatment course and 26 healthy controls, blood and knee articular car
Autor:
E. L. Luchikhina, Aleksandrova En, N. Demidova, M. Kanonirova, Galina Lukina, K. A. Kasumova, Yu. V. Muravyev, G. Gridneva, D.E. Karateev, A. А. Novikov, A. S. Avdeeva
Publikováno v:
Современная ревматология, Vol 10, Iss 4, Pp 16-20 (2016)
Russian and international clinical recommendations postulate the possibility of withdrawal of biological agents in patients with rheumatoid arthritis (RA) after the achievement of clinical remission. But it is not clear what would be the results of i
Autor:
D. S. Novikova, Alexander Volkov, E. L. Luchikhina, Novikov Aa, Evgeny Nasonov, Tatiana Popkova, Aleksandrova En, Dmitry Karateev, Galina Lukina
Publikováno v:
Journal of Korean Medical Science
The aim of the study was to examine lipid profiles, arterial stiffness (AS), carotid intima-media thickness (cIMT), in 55 women with RA without overt cardiovascular disease (СVD) treated with rituximab (RTX).The following parameters were recorded be
Autor:
Aleksandrova En, Alexander Volkov, E. Markelova, Tatiana Popkova, A.A. Novikov, E. Yu. Panasyuk, A. S. Avdeeva, I. Kirillova, Nasonov El, D. S. Novikova, E. V. Udachkina
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 11, Iss 5, Pp 510-516 (2015)
Background. According to the some studies tocilizumab therapy (TCZ) in patients with rheumatoid arthritis (RA) is accompanied by deterioration of blood lipid profile. Aim. To study changes in serum lipid parameters in patients with RA treated with a
Publikováno v:
Annals of the Rheumatic Diseases. 79:871.2-872
Background:A group of patients with recent onset of arthritis always presents a certain difficulty for the practitioner due to its marked heterogeneity. This especially concerns the patients with undifferentiated inflammatory arthritis (UIA).Objectiv